C

CNS Healthcare | Clinical Neuroscience Solutions - Memphis

Research site

(Unclaimed)

Location

6401 Poplar Avenue, Suite 420, Memphis, Tennessee, United States of America

Site insights

Top conditions

Top treatments

Methylphenidate

SPN-812

LDX

Testosterone

Cariprazine

SPN-810

Atogepant

CNP520

Loperamide

Sildenafil

Parent organization

This site is a part of CNS Healthcare

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 34 total trials

A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease (FORTIFY)

The study consists of 4 sub-studies, as follows:* Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safet...

Active, not recruiting

Crohn's Disease

Drug: Placebo for Risankizumab IV

Drug: Risankizumab SC

Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule)

Open label extension, long-term multicenter study of safety and efficacy of SPN-812 in pediatric ADHD patients

Active, not recruiting

Attention-Deficit/Hyperactivity Disorder

Drug: SPN-812

Parallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obs...

Active, not recruiting

OSA

Drug: AD109

Drug: Placebo